Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H10 Trial: PET-Guided Treatment in Early Hodgkin's Lymphoma
NCT00433433Phase 3Unknown
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Oct 2006
- Primary completion
- Dec 2011
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doxorubicin, bleomycin, vinblastine, dacarbazine, cyclophosphamide in Hodgkin lymphoma (HL), sponsored by European Organisation for Research and Treatment of Cancer. Status: unknown.
02
Drugs
doxorubicinbleomycinvinblastinedacarbazinecyclophosphamide
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00433433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433433.